Clinical Studies

GILEAD - sofosbuvir trial

A clinical trial, sponsored by Gilead, to determine the effects of sofosbuvir on ~600 patients with chronic hepatitis C has now been completed - 42% of patients were recruited in the UK (25 sites). Clinical findings from the trial were presented at the European Association for the Study of Liver meeting, in Vienna, 22-26 April 2015, and have been published in Gastroenterology (Foster et al., 2015 Nov 49(6):1462-70)